Cargando…
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
BACKGROUND: Behcet's disease (BD) is a chronic relapsing multisystem inflammatory disorder with mucocutaneous, ocular, articular, vascular, gastrointestinal and central nervous system manifestations. Tumor necrosis factor (TNF)-alpha is believed to play a pivotal role in BD. Therapeutic blockad...
Autores principales: | Gulli, Salvatore, Arrigo, Carlo, Bocchino, Loredana, Morgante, Lucia, Sangari, Donatella, Castagna, Irene, Bagnato, Gian Filippo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC194711/ https://www.ncbi.nlm.nih.gov/pubmed/12946278 http://dx.doi.org/10.1186/1471-2474-4-19 |
Ejemplares similares
-
Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor α monoclonal antibody (Infliximab)
por: Lee, Jung Hoon, et al.
Publicado: (2007) -
Bone Mineral Density, Bone Turnover Markers and Fractures in Patients with Systemic Sclerosis: A Case Control Study
por: Atteritano, Marco, et al.
Publicado: (2013) -
Efficacy of Calcineurin Inhibitors for Induction of Remission in Intestinal Behçet’s Disease
por: Kawaguchi, Takaaki, et al.
Publicado: (2022) -
Erythema nodosum in Behçet’s disease in remission: Think COVID-19?
por: El Hasbani, Georges, et al.
Publicado: (2023) -
PW03-012 – Unmet need in Behçet's disease: remission is rare
por: Alibaz-Oner, F, et al.
Publicado: (2013)